SJ Medical
SJ Medical
In the high-stakes environment of interventional cardiology, Intravascular Ultrasound (IVUS) has emerged as the gold standard for precision PCI (Percutaneous Coronary Intervention). Unlike traditional angiography, which provides a 2D silhouette of the vessel lumen, IVUS offers a cross-sectional perspective that allows clinicians to see through the vessel wall. As leading Intravascular Ultrasound suppliers and exporters, we understand that providing equipment is only half the battle; the real value lies in the Information Gain—enabling physicians to optimize stent expansion, identify lesion morphology, and significantly reduce MACE (Major Adverse Cardiovascular Events).
IVUS provides high-resolution imaging of coronary arteries, allowing for accurate measurement of vessel diameter and lesion length, ensuring the selection of the correct stent size.
By identifying edge dissections, malapposition, and under-expansion, IVUS-guided PCI reduces the risk of stent thrombosis and restenosis by up to 35%.
Differentiate between lipid-rich, fibrous, and calcified plaques to tailor the treatment strategy, including the use of lithotripsy or atherectomy.
The global medical device landscape is shifting, with China-based manufacturing centers like Hangzhou becoming hubs for high-tech vascular intervention tools. The China Factory advantage is no longer just about cost-efficiency; it is about the integration of rapid R&D cycles, sophisticated cleanroom environments, and a robust component ecosystem.
From precision balloon forming to advanced sensor assembly, Chinese exporters maintain control over the entire production stack, ensuring consistency and rapid scalability.
With thousands of clinical trials conducted annually in China, manufacturers can iterate device designs based on real-world physician feedback faster than traditional Western markets.
Strategically located near major ports like Shanghai and Ningbo, we ensure that critical diagnostic tools reach global hospitals with minimal lead times and cold-chain integrity where required.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency.
Entering international markets as an IVUS exporter requires more than just high-quality hardware. It requires a deep understanding of local regulatory frameworks and clinical workflows. From CE Mark (MDR) in Europe to CFDA/NMPA in China and various Free Sale Certificates (FSC) for Southeast Asia, the barriers to entry are high, ensuring only the most reliable suppliers survive.
We provide full dossier support for local registrations, ensuring that our distributors can navigate the complexities of MOH (Ministry of Health) approvals efficiently.
Modern IVUS systems are complex. We provide localized training materials, software interfaces, and technical support to bridge the gap between engineering and clinical application.
Recognizing that different regions have varying electrical standards and clinical theater sizes, our equipment is designed for global compatibility and ergonomic flexibility.
The Intravascular Ultrasound market is projected to grow at a CAGR of over 6% through 2030. Key drivers include an aging global population, the rising prevalence of diabetes, and the increasing complexity of coronary lesions being treated via minimally invasive methods. As a growth-focused supplier, we are monitoring three critical trends:
SJ Medical focuses on the development of vascular interventional devices designed for both coronary and peripheral procedures. Its product range integrates interventional access systems, diagnostic catheters, and therapeutic devices, forming a complete solution for minimally invasive vascular treatments. Each product is developed with an emphasis on precision, safety, and clinical performance, aiming to support physicians in achieving optimal procedural outcomes.
The company’s products are widely applied in minimally invasive procedures involving both coronary and peripheral vascular systems. They play an important role in the diagnosis and treatment of vascular diseases, helping to improve procedural efficiency while enhancing patient safety and recovery.
SJ Medical strictly adheres to international quality standards and regulatory requirements. The company has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval, along with free sale certificates, demonstrating its strong commitment to product quality and compliance.
The company is equipped with advanced production and inspection systems, including precision balloon forming equipment, laser welding and marking technologies, and comprehensive laboratory testing facilities. These capabilities ensure high levels of manufacturing accuracy, product consistency, and full-process quality control.
SJ Medical has established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Its products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt, among others. The company continues to expand its international footprint and strengthen its global presence.
SJ Medical is committed to providing comprehensive and professional services throughout the entire customer journey. From pre-sales consultation and technical support to efficient order processing and responsive after-sales service, the company ensures that every customer receives timely assistance and reliable solutions.
A: Sourcing from China offers a unique combination of high-precision manufacturing, competitive pricing due to a massive internal ecosystem, and rapid innovation. Top suppliers like SJ Medical utilize state-of-the-art GMP facilities and maintain certifications like CE and ISO 13485 to ensure global quality standards.
A: While angiography provides a "road map," IVUS provides the "topography." IVUS allows for the visualization of the vessel wall and plaque, which helps in identifying the true vessel size—often revealing that angiography significantly underestimates the diameter, leading to under-sized stents.
A: Reputable exporters provide comprehensive technical training, clinical application support, and a robust warranty program. This often includes remote diagnostics and localized maintenance via certified regional partners.
A: Most modern IVUS systems are designed with DICOM compatibility and can be integrated into existing hospital PACS networks, ensuring seamless data transfer and patient record management.
